DRAIN-1: Temporary Application of Abdominal Jackson-Pratt Drain to Reduce Pain After Laparoscopic Surgery in Gynecology

Sponsor
Università degli Studi dell'Insubria (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT03440086
Collaborator
(none)
94
1
2
24.5
3.8

Study Details

Study Description

Brief Summary

Recent evidence has shown that the onset and intensity of post-operative pain are significantly related to the amount of residual pneumoperitoneum at the end of the surgical procedure. In addition, the use of low pressures of carbon dioxide (CO2) for induction of the pnemoperitoneum has been associated with a reduction in post-operative pain, probably due to a lower abdominal distension and a consequent reduced compression of the pelvic, abdominal and sub-diaphragmatic pain nerve fibers.

The reduction of the residual pnemoperitoneum at the end of the surgical procedure could therefore play a key role in the reduction of post-operative pain, with consequent greater comfort for the patient and reduction of the use of analgesics.

In view of the available evidence, the aim of the present study is to evaluate whether the application of Jackson-Pratt drain, for one hour from the end of the surgical procedure, can significantly reduce post-operative pain and the need of analgesics in patients undergoing laparoscopic gynecological surgery.

Condition or Disease Intervention/Treatment Phase
  • Device: abdominal Jackson-Pratt drain
N/A

Detailed Description

Laparoscopy in gynecological surgery offers numerous advantages, such as the reduction of operative time, intra-operative blood loss, post-operative pain and the possibility of early hospital discharge and return to normal daily activities in a short time.

Despite these points arewidely validated in the literature, sometimes patients undergoing laparoscopy complain of abdominal pains (although slight in intensity and temporary) in the post-operative period. In some cases, the pain is characteristically irradiated at the shoulders, due to a probable irritation/compression of the phrenic nerve that runs on the lower surface of the diaphragm.

Recent evidence has shown that the onset and intensity of post-operative pain are significantly related to the amount of residual pneumoperitoneum at the end of the surgical procedure. In addition, the use of low pressures of carbon dioxide (CO2) for induction of the pnemoperitoneum has been associated with a reduction in post-operative pain, probably due to a lower abdominal distension and a consequent reduced compression of the pelvic, abdominal and sub-diaphragmatic pain nerve fibers.

The reduction of the residual pnemoperitoneum at the end of the surgical procedure could therefore play a key role in the reduction of post-operative pain, with consequent greater comfort for the patient and reduction of the use of analgesics.

In view of the available evidence, the aim of the present study is to evaluate whether the application of Jackson-Pratt drain, for one hour from the end of the surgical procedure, can significantly reduce post-operative pain and the need of analgesics in patients undergoing laparoscopic gynecological surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
94 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized controlled trial (no blinded)Randomized controlled trial (no blinded)
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Evaluation of One-hour Application of Abdominal Jackson-Pratt Drain in Order to Reduce Pain After Laparoscopic Surgery in Gynecology
Anticipated Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Jun 15, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Abdominal Jackson-Pratt drain

Patients in this arm will undergo one-hour application of abdominal Jackson-Pratt drain at the end of laparoscopic procedure.

Device: abdominal Jackson-Pratt drain
One-hour application of abdominal Jackson-Pratt drain at the end of laparoscopic procedure.

No Intervention: Controls

Patients in this arm will not undergo one-hour application of abdominal Jackson-Pratt drain at the end of laparoscopic procedure.

Outcome Measures

Primary Outcome Measures

  1. Pain [6 hours after surgery.]

    Pain perception, expressed as Visual Analogue Score (0-10).

Secondary Outcome Measures

  1. Pain [12 hours after surgery.]

    Pain perception, expressed as Visual Analogue Score (0-10).

  2. Pain [24 hours after surgery.]

    Pain perception, expressed as Visual Analogue Score (0-10).

  3. Use of Analgesic [During the 48 hours after surgery.]

    Number of requests for rescue analgesia (30 mg ketorolac tromethamine, administrated intravenously).

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients affected by uterine fibroids, undergoing laparoscopic surgery;

  • American Society of Anesthesiologists physical status classification I-II.

Exclusion Criteria:
  • inability to express pain;

  • any concomitant diseases requiring upper abdominal surgery, such as cholecystectomy or adhesiolysis;

  • laparoscopic procedures that were converted to open surgery;

  • other causes of known pain;

  • oncological cases;

  • use of drugs for chronic pelvic pain or hormones in the previous 3 months (wash-out period);

  • application of other drainages;

  • intra- or post-operative complications.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Insubria Varese Italy 21100

Sponsors and Collaborators

  • Università degli Studi dell'Insubria

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Antonio Simone Laganà, Medical Doctor, Università degli Studi dell'Insubria
ClinicalTrials.gov Identifier:
NCT03440086
Other Study ID Numbers:
  • DRAIN-1
First Posted:
Feb 20, 2018
Last Update Posted:
Sep 30, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Antonio Simone Laganà, Medical Doctor, Università degli Studi dell'Insubria
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 30, 2021